TradeFlare's AI research teams analysed ARKG on 18 market nights between May 15, 2026 and October 13, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| October 13, 2026 | HOLD | $49.48 | — / — | not yet | not yet | The current setup does not warrant a buy, and a HOLD is appropriate given the conflicting signals. |
| October 9, 2026 | HOLD | $49.29 | — / — | not yet | not yet | The current setup does not warrant a buy, and the market regime is neutral, suggesting caution. |
| October 8, 2026 | HOLD | $50.14 | — / — | not yet | not yet | The current setup does not warrant a BUY, and a HOLD is appropriate given the conflicting signals. |
| September 18, 2026 | HOLD | $51.59 | — / — | +3.3% | not yet | The current market regime and ARKG's technical and fundamental profiles do not support a buy decision at this time. |
| August 27, 2026 | HOLD | $49.45 | — / — | -5.3% | +7.0% | ARKG's technical setup is near a breakout, but fundamental and risk factors warrant caution. |
| August 26, 2026 | HOLD | $50.06 | — / — | -4.7% | +8.2% | Continued positive momentum in the genomics sector. |
| August 24, 2026 | BUY | $49.45 | — / — | -1.6% | +10.1% | Continued momentum in the genomics sector. |
| August 22, 2026 | BUY | $49.45 | — / — | -1.6% | +10.1% | Continued optimism in the genomics sector. |
| August 13, 2026 | HOLD | $44.69 | — / — | +7.5% | +2.8% | Advancements in genomics and biotech driving sector interest. |
| July 30, 2026 | BUY | $37.50 | — / — | +3.3% | +27.0% | Potential for a broad market rally to lift speculative assets. |
| July 29, 2026 | BUY | $37.82 | — / — | +10.0% | +31.9% | The current market regime and ARKG's technical and fundamental outlook do not support a buy. |
| July 28, 2026 | BUY | $37.79 | — / — | +7.6% | +32.4% | Potential for a broad market rally to lift speculative ETFs like ARKG. |
| July 27, 2026 | HOLD | $37.81 | — / — | +4.8% | +27.0% | No immediate catalysts identified for a bullish reversal. |
| July 21, 2026 | BUY | $38.28 | — / — | -4.4% | +9.2% | Potential for a broad market recovery to lift speculative growth ETFs. |
| June 19, 2026 | BUY | $36.86 | — / — | +16.4% | +8.7% | The current market regime and ARKG's conflicting team scores necessitate a cautious approach, favoring a HOLD until a clearer directional signal emerges. |
| May 19, 2026 | BUY | $28.15 | — / — | +14.0% | +24.6% | No clear bullish catalyst identified in the current market regime. |
| May 18, 2026 | BUY | $28.15 | — / — | +11.3% | +24.1% | No clear bullish catalyst identified in the current market regime. |
| May 15, 2026 | BUY | $29.18 | $30.52 / $25.05 | +8.9% | +24.7% | The current market regime and ARKG's neutral technicals and bearish fundamentals necessitate a cautious approach. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.